Blue Jet Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on May 25, 2026.
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Blue Jet Healthcare's Board approved audited FY2026 standalone results showing total income of Rs. 10,762.41 million and PAT of Rs. 2,478.16 million, with EPS of Rs. 17.59. Profitability declined vs FY2025 (PAT was Rs. 3,052.03 million) due to lower revenues. The Board recommended a final dividend of Rs. 1.2 per share (60% payout on face value Rs. 2), subject to shareholder approval at the ensuing AGM. Separately, the Board approved a proposal to raise funds of up to Rs. 10,000 million (Rs. 1,000 crore) via equity shares, convertible instruments, QIP, preferential issue, or private placement — an EGM is scheduled for June 17, 2026 for shareholder approval. The statutory auditors issued an unmodified opinion on the financials.
The profit decline year-on-year may concern investors, though the 60% dividend payout signals management confidence. The Rs. 1,000 crore fundraise plan could dilute equity and warrants close monitoring for quantum and pricing.